Back to Trials
NCT00748254RecruitingAccepts Healthy Volunteers

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

University of Michigan

Start Date

12/1/2011

Completion Date

1/1/2027

Summary

The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of chronic rheumatoid arthritis.

Detailed Description

The objective of this proposal is to adapt photoacoustic tomography (PAT), a novel, nonionizing, noninvasive, laser-based technology, for structural and functional imaging of human peripheral joints affected by inflammatory arthritis. Combining the advantages of both light and ultrasound scanning, PAT holds promise to present objective optical information in subsurface joint tissues with high sensitivity and high spatial resolution. This could be of considerable help in the early detection of inflammatory joint diseases. PAT may also prove useful in further understanding the pathophysiology of these disorders and assisting with therapeutic decisions, including assessment of new pharmacological therapies. In January 2026, the decision was made to reopen recruitment for this study to collect additional data to support future clinical trial work and funding.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: * Men and women 18 years of age or older can participate in this study. * Patients can participate in this study if they have had rheumatoid arthritis for more than 2 years and their rheumatologist has referred them to this study. * Patients can participate as a healthy volunteer with a known history of rheumatoid arthritis. Exclusion Criteria: * Patients, who have electrically, magnetically or mechanically activated implants such as heart pacemaker, magnetic surgical clips, prostheses or implanted neurological stimulator. * Pregnant patients. * Patients who is claustrophobic. * Patients with impaired renal function cannot participate in this study such as elevate creatinine clearance, patients on kidney dialysis etc. * Patients with shock hypotension or unstable low blood pressure. * Patients with Rhabdomyolysis. * Patients who have had a contrast enhanced (with gadolinium) MRA (magnetic resonance angiography)/ or MRI within the last 3 months. (Contrast is a medication injected into a vein during a imaging examination that helps produce clearer images/pictures).

Interventions

PROCEDURE

Laser Based Photoacoustic Tomography, MRI, Ultrasound

PROCEDURE

laser based photoacoustic tomography, MRI, ultrasound

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Arthritis, Rheumatoid

Locations

Universtity of Michigan Health System

Ann Arbor, Michigan 48109

United States